Consequently, it is easy to understand why decreased ISGylation results in an increased phenotypic sensitivity to IFN-α in several hepatoma derived cell lines or even nonhepatic cell lines [16, 30]. The gene discussed is IFNA1; the disease is hepatocellular carcinoma.